• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LI Xin,LIU Xiaoying,JIANG Lei,YANG Bo,PANG Haisheng.Analysis of mechanism of Danshen-Chuanxiong-Gegen on antihypertensive based on network pharmacology technology and molecular docking[J].Journal Of Pharmaceutical Research,2022,41(6):357-364,372[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2785times   Download 3430次 QR Code for this article
Scan with your phone!
基于网络药理学及分子对接技术分析丹参-川芎-葛根抗高血压的分子机制
李新1,刘肖莹2,蒋蕾2,杨波1,彭海生2
Font:Larger+|Default|Smaller-
(1.哈尔滨商业大学药学院,黑龙江 哈尔滨 150076;2.哈尔滨医科大学大庆校区药学院,黑龙江 大庆 163319)
摘要:
目的 运用网络药理学及分子对接技术探究丹参-川芎-葛根有效活性成分抗高血压的相关靶点及分子机制。方法 通过检索TCMSP、Uniport数据库,获得丹参-川芎-葛根的主要活性成分和相关靶点。通过Genecards数据库获得高血压相关靶点。运用Venny数据库构建丹参-川芎-葛根和疾病靶点韦恩图,得到交集靶点;并将得到的交集靶点导入STRING数据库得到蛋白质相互作用关系。使用RStudio 1.4.1106软件对交集靶点进行GO功能富集和KEGG信号通路富集分析。并利用Cytoscape 3.6.0软件对“药材-活性成分-靶点”、蛋白质-蛋白质相互作用(PPI)、“活性成分-靶点-通路”网络进行可视化。采用AutoDock Tools 1.5.6软件将关键活性成分和核心靶点进行分子对接,运用PyMOL对对接结果进行可视化。结果 通过筛选共获得68个活性成分,759个高血压相关靶点,62个交集靶点。经KEGG通路富集分析发现,丹参-川芎-葛根通过调节流体剪切应力和动脉粥样硬化、钙信号通路、AGE-RAGE、松弛素、cGMP-PKG等通路起到抗高血压的作用。分子对接结果显示,丹参酮ⅡA、隐丹参酮、β-谷甾醇与NOS3、FOS、VEGFA、AKT1等核心靶点结合能力较好。结论 证实了丹参-川芎-葛根多成分、多靶点、多途径的作用规律。
关键词:  丹参-川芎-葛根  网络药理学  分子对接  高血压  分子机制
DOI:10.13506/j.cnki.jpr.2022.06.002
基金项目:黑龙江省自然科学基金联合引导项目(No.LH2019H011)
Analysis of mechanism of Danshen-Chuanxiong-Gegen on antihypertensive based on network pharmacology technology and molecular docking
LI Xin1,LIU Xiaoying2,JIANG Lei2,YANG Bo1,PANG Haisheng2
(1. Department of Pharmacy, Harbin University of Commerce, Harbin 150076, China;2.Department of Pharmacy, Daqing Campus, Harbin Medical University, Daqing 163319,China)
Abstract:
Objective To explore the relevant targets and molecular mechanisms of the effective active ingredients of Danshen-Chuanxiong-Gegen against hypertension, using network pharmacology and molecular docking technology. Methods The main active ingredients and related targets were obtained by searching the TCMSP and Uniport databases. Hypertension-related targets were obtained through the Genecards database.Venny database was used to obtain the Venn diagram of Tongmai particles, disease targets and the intersection targets. The protein interaction relationship was obtained by importing the intersection targets into the STRING database. The GO function enrichment and KEGG signal pathway enrichment analysis of intersection targets were carried out by RStudio-1.4.1106 software. The "medicine-active ingredient-target", protein-protein interaction (PPI) and "active ingredient-target-pathway" network were visualized by Cytoscape3.6.0 software. The key active ingredients and core targets were molecularly docked through AutoDock Tools 1.5.6 software, and the docking results were visualized with PyMOL. Results A total of 68 active components ,759 hypertension related targets and 62 intersection targets were obtained by screening. KEGG pathway enrichment analysis shows that antihypertensive effects were achieved by regulating fluid shear stress and atherosclerosis, calcium signaling pathway, AGE-RAGE, relaxin, cGMP-PKG and other pathways by Danshen-Chuanxiong-Gegen. The molecular docking results shows that the binding ability was better between tanshinone ⅡA, cryptotanshinone, β-glutanol and NOS3, FOS, VEGFA, AKT1 and other core targets. Conclusion This study shows that the new ideas for further study of molecular mechanism in the future are through the multi-component, multi-target, and multi-channel action law of Danshen-Chuanxiong-Gegen.
Key words:  Danshen-Chuanxiong-Gegen  Network pharmacology  Molecular docking  Hypertensive  Molecular mechanism
Today's Visits:488    Total Visits:2383203
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.